NO20010487L - Disubstituert maleimidforbindelse og farmasøytisk anvendelse herav - Google Patents

Disubstituert maleimidforbindelse og farmasøytisk anvendelse herav

Info

Publication number
NO20010487L
NO20010487L NO20010487A NO20010487A NO20010487L NO 20010487 L NO20010487 L NO 20010487L NO 20010487 A NO20010487 A NO 20010487A NO 20010487 A NO20010487 A NO 20010487A NO 20010487 L NO20010487 L NO 20010487L
Authority
NO
Norway
Prior art keywords
maleimide compound
pkc
alkyl
hydrogen
ring
Prior art date
Application number
NO20010487A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010487D0 (no
Inventor
Takashi Inaba
Masahiro Tanaka
Kenji Sakoda
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of NO20010487D0 publication Critical patent/NO20010487D0/no
Publication of NO20010487L publication Critical patent/NO20010487L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20010487A 1998-07-30 2001-01-29 Disubstituert maleimidforbindelse og farmasøytisk anvendelse herav NO20010487L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21507098 1998-07-30
PCT/JP1999/004085 WO2000006564A1 (fr) 1998-07-30 1999-07-28 Composes de maleimide disubstitues et utilisation en medecine de ces derniers

Publications (2)

Publication Number Publication Date
NO20010487D0 NO20010487D0 (no) 2001-01-29
NO20010487L true NO20010487L (no) 2001-03-28

Family

ID=16666269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010487A NO20010487L (no) 1998-07-30 2001-01-29 Disubstituert maleimidforbindelse og farmasøytisk anvendelse herav

Country Status (12)

Country Link
EP (1) EP1120414A1 (fr)
KR (1) KR20010085305A (fr)
CN (1) CN1320123A (fr)
AU (1) AU4929999A (fr)
BR (1) BR9912612A (fr)
CA (1) CA2338866A1 (fr)
HU (1) HUP0103381A3 (fr)
ID (1) ID27510A (fr)
IL (1) IL141080A0 (fr)
NO (1) NO20010487L (fr)
PE (1) PE20000945A1 (fr)
WO (1) WO2000006564A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6111699A (en) * 1998-10-08 2000-05-01 Smithkline Beecham Plc Novel method and compounds
US6719520B2 (en) 1998-10-08 2004-04-13 Smithkline Beecham Corporation Method and compounds
WO2001013916A1 (fr) * 1999-08-20 2001-03-01 Sagami Chemical Research Center Medicaments inhibant la mort cellulaire
GB0008264D0 (en) * 2000-04-04 2000-05-24 Smithkline Beecham Plc Novel method and compounds
BR0116468A (pt) 2000-12-08 2004-06-29 Ortho Mcneil Pharm Inc Compostos de pirrolina substituìda por indazolila como inibidores de cinase
BR0212676A (pt) * 2001-09-21 2006-05-23 Upjohn Co compostos terapêuticos ligantes de 5-ht, composições farmacêuticas compreendendo tais compostos e seus usos
TW200918046A (en) * 2002-04-03 2009-05-01 Novartis Ag Indolylmaleimide derivatives
JP2005531607A (ja) 2002-06-05 2005-10-20 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ キナーゼ阻害剤として置換ピロリン
EP1513830A1 (fr) 2002-06-05 2005-03-16 Janssen Pharmaceutica N.V. Derives de bisindolyl-maleimide utilises en tant qu'inhibiteurs de kinase
EP1654255B1 (fr) 2003-06-13 2008-08-27 Janssen Pharmaceutica N.V. Derives substitues indazolyl(indolyl)maleimide, inhibiteurs de kinase
GB0316232D0 (en) 2003-07-11 2003-08-13 Astrazeneca Ab Therapeutic agents
MX2007005199A (es) 2004-11-01 2007-05-11 Wyeth Corp Indolizinas sustituidas y derivados como agentes del sistema nervioso central.
KR100941205B1 (ko) 2005-02-09 2010-02-10 아르퀼 인코포레이티드 말레이미드 유도체, 약제학적 조성물 및 암을 치료하는방법
KR20100024494A (ko) 2007-06-22 2010-03-05 아르퀼 인코포레이티드 퀴나졸리논 화합물 및 이의 사용 방법
CA2912546A1 (fr) 2007-06-22 2008-12-31 Arqule, Inc. Compositions et procedes de traitement du cancer
EP2170870B1 (fr) * 2007-06-22 2014-03-05 ArQule, Inc. Dérivés de pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine et thiosuccinimide, compositions et procédés pour le traitement d'un cancer
CN101671329B (zh) * 2009-06-17 2012-11-07 东华大学 3-氨基醇取代的吲哚马来酰亚胺化合物、其制备和应用
CN102344443A (zh) * 2011-07-15 2012-02-08 南开大学 点击化学合成开环马来酰亚胺类化合物及其在治疗疾病中的应用
WO2013029043A1 (fr) * 2011-08-25 2013-02-28 Reaction Biology Corp. Inhibiteurs sélectifs de kinase
CN112574163B (zh) * 2021-01-29 2023-04-07 山西省肿瘤研究所 巴西苏木素类天然产物(+)-Brazilin的合成方法
WO2025165835A1 (fr) * 2024-01-31 2025-08-07 Ensem Therapeutics, Inc. Composés tricycliques d'aniline, compositions et méthodes associés

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005970A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte maleinimide, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
GB9123396D0 (en) * 1991-11-04 1991-12-18 Hoffmann La Roche A process for the manufacture of substituted maleimides

Also Published As

Publication number Publication date
KR20010085305A (ko) 2001-09-07
HUP0103381A2 (hu) 2002-02-28
ID27510A (id) 2001-04-12
CA2338866A1 (fr) 2000-02-10
BR9912612A (pt) 2001-11-20
IL141080A0 (en) 2002-02-10
NO20010487D0 (no) 2001-01-29
CN1320123A (zh) 2001-10-31
EP1120414A1 (fr) 2001-08-01
WO2000006564A1 (fr) 2000-02-10
AU4929999A (en) 2000-02-21
PE20000945A1 (es) 2000-09-25
HUP0103381A3 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
NO20010487L (no) Disubstituert maleimidforbindelse og farmasøytisk anvendelse herav
EA200100230A1 (ru) Производные 1h-имидазопиридина
RU94016183A (ru) Производные пиперазина
NO965524L (no) Tri-substituerte fenylderivater anvendelige som PDE IV inhibitorer
DK1063228T5 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
AU7517400A (en) N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
PL247096A1 (en) Agent for fighting against and/or preventing paralyzing effects of microorganisms and method of obtaining new derivatives of n-/2-nitrophenylo/-4-aminopyrimidines
ES2036562T3 (es) Un procedimiento para produccion de un derivado de pirrolidinamida.
BRPI0414738A (pt) derivados de ácido acético substituìdos
SV2002000244A (es) Metodos y compuestos para inhibir mrp1 ref.x-13353
DK534381A (da) Fremgangsmaade til fremstilling af 2-oxoazetidinderivater
WO2003018549A3 (fr) Composes bicycliques servant d'inhibiteurs de chimiokine se fixant a l'us28
RU2008119994A (ru) Ингибиторы калиевых каналов
NO971687D0 (no) Diazepinoindoler som forsfodiesterase IV-inhibitorer
CA2042113A1 (fr) Spiro-isoquinoleinepyrrolidine et leurs analogues, utiles comme agents inhibiteurs de l'aldose-reductase
NO904801L (no) Fremgangsmaate for fremstilling av acat-inhibitorer.
AU2001255646A1 (en) Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
WO1999003817A3 (fr) Propargylamines aliphatiques employes comme antidotes electifs
ATE239741T1 (de) Derivate der phosphonsäure zur inhibierung von carboxypeptidase b
KR960706476A (ko) 인터류킨-1 활성 억제제로서의 신규한 벤젠설포닐아민 유도체(Novel benzen-esulfonylimine derivatives as inhibitors of lL-1 action)
DE60112091D1 (de) Verfahren zur herstellung von azacycloalkanoylaminothiazolen
EA200300010A1 (ru) Производные 2-аминотиазолина и их применение в качестве ингибиторов no-синтазы
WO2002004423A8 (fr) Inhibiteurs de thrombine contenant un groupe aminoisoquinoline
BR0307424A (pt) Compostos heterocìclicos com atividade inibidora de elastase e seus intermediários

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application